Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes - Wikidata - awgldk - TriplyDB

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

http://www.wikidata.org/entity/Q24623082

about

Advancing cardiovascular tissue engineering Distilling complexity to advance cardiac tissue engineering Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?An integrated in vitro model of perfused tumor and cardiac tissue In vitro organogenesis from pluripotent stem cells Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses.Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues Industry Update: Latest developments in stem cell research and regenerative medicine Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.Three-dimensional filamentous human diseased cardiac tissue model.Combined biophysical and soluble factor modulation induces cardiomyocyte differentiation from human muscle derived stem cells Human iPSC-based cardiac microphysiological system for drug screening applications.Machine learning plus optical flow: a simple and sensitive method to detect cardioactive drugs Tissue Contraction Force Microscopy for Optimization of Engineered Cardiac Tissue.Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues.Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues.Tubular Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells Generate Pulse Pressure In Vivo.Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue.Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes.Naturally Engineered Maturation of Cardiomyocytes Role of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineering Controlling the structural and functional anisotropy of engineered cardiac tissues.Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles.Use of myocardial matrix in a chitosan-based full-thickness heart patch Pluripotent stem cell derived cardiomyocytes for cardiac repair.Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation.Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells.Human stem cells for modeling heart disease and for drug discovery.HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair.Reprogramming for cardiac regeneration.On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.

P2860

Q26745911-8F907888-87AD-49A3-9A72-228C6816979B Q26747338-FC21DEBC-42E9-4FE3-829F-6DF0030DDC97 Q26799470-0B8AC942-3A55-4071-8698-CA05E74879AF Q26800082-52977283-422A-4089-B63B-F671130619D4 Q26822867-B5E6CB6F-D12F-481A-A8C7-3F0F84EEDC14 Q26830099-6161180D-BAFC-4C25-AD0C-369CD528D434 Q27303626-C1E9F35F-8FC1-400F-A943-9BCB7C5038A2 Q27307789-A5BE19F9-A74F-4536-A7B8-0F553B55421A Q27320368-20DC6B0F-CAFE-4496-BA7C-91BB15E97C25 Q27335280-9D8FF024-D624-4905-AC0C-FDE045E9BAFA Q28076397-378DF670-63B9-469A-A683-F1FE6E8E430A Q28084360-F213411A-66C3-4443-A2EC-097A79EF1C67 Q28087290-AEB42546-6695-4D97-B56A-D071FA443FAD Q28550738-AD5100B0-4697-46D2-9F71-356C2802B2D1 Q29398571-1858CE88-B892-4423-BD90-B0FA12EDE5A0 Q30566351-F0C6F9AC-4BB2-4ABA-9773-6DF25AD0E309 Q30567430-3006AECF-6B60-4A18-9FEE-1119A7D5D37B Q30591797-79267294-59B6-4EE8-AAF9-3ED507B36440 Q30625616-EE02716B-9EE3-435B-8B77-EFDDA6A148F6 Q30656460-6903D66E-F9B6-4C2E-A0C6-B0FBC4D0CF97 Q30700000-C77BDDCF-FF36-4E36-B32A-86F2C2AF74E4 Q30731784-3B3601A0-72D1-4BDD-B64B-13B6E61BCC64 Q30838004-F3FD30A6-A4D1-4536-8F00-C8B913B483FF Q30843275-F5F9B313-983C-403B-A3AA-F6DF71A8673E Q30843677-99EDFB38-4B1C-4710-BDA7-D68E249052FF Q33631149-5AB44B34-3C47-4B92-87CB-6EBE3BCDCF1A Q33639096-F4082E5A-47D5-4416-92D8-599CE7A88D66 Q33649957-E65106CB-1A91-48F9-BF40-9D0214342AB4 Q33692557-D74699CD-AC14-44CD-8996-76A26A335DE2 Q33704567-035A1152-5BC3-4C44-895F-B8E6B10D7449 Q33800913-3B20DA9F-E557-4B03-BFDF-3C083F1CC211 Q33862440-2870B021-FF7E-4FBB-B9D4-7F24AD41EA30 Q33875374-8C9DFDC6-5C7E-4849-9B39-94B2D5F4F70D Q33939491-70EF78F9-EB92-45E5-AB3E-1E67CAB78B03 Q34246093-C82EB545-B84B-4550-A597-7097F20C44C0 Q34433363-5AA2FC73-467F-489E-89FD-547DEE79DE55 Q34491330-7ADB0281-D284-4C76-AAC1-C84C9A1A7E99 Q34947905-5FD8C67A-F744-4CEE-AB70-0F29C9DC230B Q35156623-668A17F7-AA7A-4523-841D-B98BCB3A69E4 Q35232473-4D3FB126-6ACD-4F0F-BBD2-B73053041572

P2860

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

http://www.wikidata.org/entity/Q24623082

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@ast

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@en

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@nl

type

label

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@ast

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@en

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@nl

prefLabel

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@ast

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@en

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@nl

P1433

Q24623082-2A09C233-E04D-4E86-AFA2-9611D1CA3B32

P1476

Q24623082-968DF0E3-AD87-4EA8-AD43-55D47FB6BE12

P2093

Q24623082-2A7585E5-BE7C-4C51-A11E-5DFB97FD7A03

Q24623082-5500ACDE-32C4-404B-BBCF-17CE90F0758E

Q24623082-79F00221-BE81-4577-A1C6-5D1BD27047DA

Q24623082-7AE00201-C741-4920-87D0-00F8C4FEFDD0

P2860

Q24623082-085AFB43-4A56-4343-A579-4E2967033CF0

Q24623082-0E963F34-D031-4B07-AD84-809ECA651B6F

Q24623082-127E8CBC-01BA-4F91-9EE8-76521D0A93A0

Q24623082-1701D5C7-946D-4915-A041-D45F3ECB7FB0

Q24623082-20E0F009-82BC-4819-8946-DC7D713043FB

Q24623082-3112D4FC-E714-4468-94C3-7427798A7F77

Q24623082-47CFD0D8-6BB4-47DD-9C31-E82A34FBBB4B

Q24623082-48E11CAA-0C82-4802-B2C6-66E7C5CE8858

Q24623082-4A2FBF8D-DC7E-4C45-8A6C-1A7F513CD049

Q24623082-4DF7DB7B-532B-4FC1-9B08-B9DB51E9C270

P304

Q24623082-EC73F1FC-0A2E-417A-98F7-BC7384F9566D

P31

Q24623082-5C8B2D97-50AB-4A49-98BD-24D199FCD312

P3181

Q24623082-A0977858-D7FB-47AF-AE07-3541B603B6DC

P356

Q24623082-6EE10736-CA31-4D59-8272-85B58A08255D

P407

Q24623082-14EE5573-8337-4C87-81F6-CADD1C5FABB6

P433

Q24623082-18F42EF4-9845-41B2-A5D9-193FC5EBBF7D

P478

Q24623082-97B14BFA-2A58-4A8F-A48F-35CC0BC9F114

P50

Q24623082-0CFE15AF-0A96-4666-B200-61FDC925656E

Q24623082-5BF30832-5BC6-49B0-95D2-96879BC7D256

P577

Q24623082-94CCBE88-8F39-4B2C-8836-71E9FB755E5D

P5875

Q24623082-3A316B5E-8FCC-40DB-B563-35AAB2B74EE0

P698

Q24623082-452400B2-6AD5-4448-B256-F54E02B5AB70

P921

Q24623082-3F2D0086-002F-4FA7-BF6C-E7FBCA6506F0

Q24623082-EF42DAE2-14EB-4F4D-914A-843096455F8E

P932

Q24623082-2D09B95A-3D1E-4FF7-B06D-0E733FED892E

P3181

P356

J.BIOMATERIALS.2013.04.026

P1433

P1476

Tissue-engineered cardiac patc ...... man ESC-derived cardiomyocytes

@en

P2093

Donghui Zhang

http://www.w3.org/2001/XMLSchema#string

H Ralph Snodgrass

http://www.w3.org/2001/XMLSchema#string

Hai-Qian Xian

http://www.w3.org/2001/XMLSchema#string

Jason Lam

http://www.w3.org/2001/XMLSchema#string

P2860

Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology

Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview

Growth of engineered human myocardium with mechanical loading and vascular coculture

Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.

Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues

Local tissue geometry determines contractile force generation of engineered muscle networks

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Calcium handling in human induced pluripotent stem cell derived cardiomyocytes.

P304

5813-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1194870

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BIOMATERIALS.2013.04.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236636621

http://www.w3.org/2001/XMLSchema#string

P698

23642535

http://www.w3.org/2001/XMLSchema#string

P921

P932

3660435

http://www.w3.org/2001/XMLSchema#string